These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 23200737)

  • 1. Clinical experience using intranasal ketamine in the treatment of pediatric bipolar disorder/fear of harm phenotype.
    Papolos DF; Teicher MH; Faedda GL; Murphy P; Mattis S
    J Affect Disord; 2013 May; 147(1-3):431-6. PubMed ID: 23200737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical experience using intranasal ketamine in the longitudinal treatment of juvenile bipolar disorder with fear of harm phenotype.
    Papolos D; Frei M; Rossignol D; Mattis S; Hernandez-Garcia LC; Teicher MH
    J Affect Disord; 2018 Jan; 225():545-551. PubMed ID: 28866299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fear of harm, a possible phenotype of pediatric bipolar disorder: a dimensional approach to diagnosis for genotyping psychiatric syndromes.
    Papolos D; Mattis S; Golshan S; Molay F
    J Affect Disord; 2009 Nov; 118(1-3):28-38. PubMed ID: 19631388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral Ketamine for Depression: A Systematic Review.
    Rosenblat JD; Carvalho AF; Li M; Lee Y; Subramanieapillai M; McIntyre RS
    J Clin Psychiatry; 2019 Apr; 80(3):. PubMed ID: 30995364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression.
    Diazgranados N; Ibrahim L; Brutsche NE; Newberg A; Kronstein P; Khalife S; Kammerer WA; Quezado Z; Luckenbaugh DA; Salvadore G; Machado-Vieira R; Manji HK; Zarate CA
    Arch Gen Psychiatry; 2010 Aug; 67(8):793-802. PubMed ID: 20679587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Demographic and Clinical Characteristics, Including Subsyndromal Symptoms Across Bipolar-Spectrum Disorders in Adolescents.
    Salazar de Pablo G; Guinart D; Cornblatt BA; Auther AM; Carrión RE; Carbon M; Jiménez-Fernández S; Vernal DL; Walitza S; Gerstenberg M; Saba R; Lo Cascio N; Brandizzi M; Arango C; Moreno C; Van Meter A; Correll CU
    J Child Adolesc Psychopharmacol; 2020 May; 30(4):222-234. PubMed ID: 32083495
    [No Abstract]   [Full Text] [Related]  

  • 7. The effectiveness of ketamine on anxiety, irritability, and agitation: Implications for treating mixed features in adults with major depressive or bipolar disorder.
    McIntyre RS; Lipsitz O; Rodrigues NB; Lee Y; Cha DS; Vinberg M; Lin K; Malhi GS; Subramaniapillai M; Kratiuk K; Fagiolini A; Gill H; Nasri F; Mansur RB; Suppes T; Ho R; Rosenblat JD
    Bipolar Disord; 2020 Dec; 22(8):831-840. PubMed ID: 32406161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-dose infusion ketamine and non-ketamine N-methyl-d-aspartate receptor antagonists for unipolar and bipolar depression: a meta-analysis of efficacy, safety and time trajectories.
    Kishimoto T; Chawla JM; Hagi K; Zarate CA; Kane JM; Bauer M; Correll CU
    Psychol Med; 2016 May; 46(7):1459-72. PubMed ID: 26867988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of Ketamine in bipolar depression: focus on anhedonia.
    Gałuszko-Węgielnik M; Wiglusz MS; Słupski J; Szałach Ł; Włodarczk A; Górska N; Szarmach J; Jakuszkowiak-Wojten K; Wilkowska A; Cubała WJ
    Psychiatr Danub; 2019 Sep; 31(Suppl 3):554-560. PubMed ID: 31488790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A single infusion of ketamine improves depression scores in patients with anxious bipolar depression.
    Ionescu DF; Luckenbaugh DA; Niciu MJ; Richards EM; Zarate CA
    Bipolar Disord; 2015 Jun; 17(4):438-43. PubMed ID: 25400146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal Ketamine for Abortive Migraine Therapy in Pediatric Patients: A Single-Center Review.
    Turner AL; Shandley S; Miller E; Perry MS; Ryals B
    Pediatr Neurol; 2020 Mar; 104():46-53. PubMed ID: 31902550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Family history of alcohol dependence and antidepressant response to an N-methyl-D-aspartate antagonist in bipolar depression.
    Luckenbaugh DA; Ibrahim L; Brutsche N; Franco-Chaves J; Mathews D; Marquardt CA; Cassarly C; Zarate CA
    Bipolar Disord; 2012 Dec; 14(8):880-7. PubMed ID: 22978511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intranasal drug delivery in neuropsychiatry: focus on intranasal ketamine for refractory depression.
    Andrade C
    J Clin Psychiatry; 2015 May; 76(5):e628-31. PubMed ID: 26035196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antidepressant, mood stabilizing and procognitive effects of very low dose sublingual ketamine in refractory unipolar and bipolar depression.
    Lara DR; Bisol LW; Munari LR
    Int J Neuropsychopharmacol; 2013 Oct; 16(9):2111-7. PubMed ID: 23683309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Symptomatology and predictors of antidepressant efficacy in extended responders to a single ketamine infusion.
    Pennybaker SJ; Niciu MJ; Luckenbaugh DA; Zarate CA
    J Affect Disord; 2017 Jan; 208():560-566. PubMed ID: 27839782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prescribing patterns for treatment of pediatric bipolar disorder in a specialty clinic.
    Potter MP; Liu HY; Monuteaux MC; Henderson CS; Wozniak J; Wilens TE; Biederman J
    J Child Adolesc Psychopharmacol; 2009 Oct; 19(5):529-38. PubMed ID: 19877977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapeutic management of bipolar disorder in France and Europe: a multinational longitudinal study (WAVE-bd)].
    Bellivier F; Delavest M; Coulomb S; Figueira ML; Langosch JM; Souery D; Vieta E
    Encephale; 2014 Oct; 40(5):392-400. PubMed ID: 25238903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in skin temperature and sleep in the fear of harm phenotype of pediatric bipolar disorder.
    Murphy PJ; Frei MG; Papolos D
    J Clin Med; 2014; 3(3):959-71. PubMed ID: 25530872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial.
    Zarate CA; Brutsche NE; Ibrahim L; Franco-Chaves J; Diazgranados N; Cravchik A; Selter J; Marquardt CA; Liberty V; Luckenbaugh DA
    Biol Psychiatry; 2012 Jun; 71(11):939-46. PubMed ID: 22297150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.